Summary

The UAE has a high prevalence of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. According to the World Health Organization, asthma affects around 10% of the UAE population, while COPD affects around 5%. Sleep apnea is also a common problem, affecting around 20% of the population. The main respiratory condition in the UAE is asthma, which affects over 15% of the population and accounts for just under a third of all respiratory illness cases. Additionally, lifestyle factors, including high smoking rates and a sedentary lifestyle, contribute to the burden of respiratory disorders in the UAE. Efforts are being made by the government to raise awareness about these conditions and promote healthier living to combat this growing public health challenge. Respiratory disorders caused by lifestyle factors are a significant public health concern worldwide. These conditions can have long-term and sometimes irreversible effects on an individual's respiratory health. Some reasons include; smoking is one of the most prominent lifestyle factors contributing to respiratory disorders. The inhalation of tobacco smoke leads to the development of chronic conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and bronchitis. Smoking damages the airways, cilia (tiny hair-like structures that clear mucus), and lung tissue, leading to reduced lung function and a higher risk of respiratory infections. Exposure to secondhand smoke, also known as passive smoking, can be equally harmful. People who live with or are regularly exposed to smokers are at risk of developing respiratory disorders, especially children. Secondhand smoke can lead to conditions like asthma, bronchitis, and ear infections in children. Excessive alcohol consumption and the use of certain drugs can depress the central nervous system and lead to breathing problems, such as respiratory depression. In severe cases, these substances can result in overdose and death.

According to the research report "United Arab Emirates Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market is anticipated to grow with more than 7% CAGR from 2023-2028. The respiratory monitoring device market in the UAE is expected to continue to grow in the coming years. This is due to a number of factors, including the rising prevalence of respiratory diseases, the growing geriatric population, and the increasing demand for home and remote monitoring solutions. Patients with respiratory diseases are increasingly demanding home and remote monitoring solutions. This is due to a number of factors, including the convenience of being able to monitor their condition from home, the ability to reduce their hospital visits, and the desire to have more control over their care. There have been a number of technological advancements in recent years that have made respiratory monitoring devices more affordable, accurate, and user-friendly. This has made these devices more accessible to a wider range of patients. In addition to the factors mentioned above, the COVID-19 pandemic has also had a significant impact on the respiratory monitoring device market in the UAE. The pandemic has led to an increased demand for respiratory monitoring devices, both in hospitals and in homes. This is because COVID-19 can cause a variety of respiratory problems, including pneumonia and acute respiratory distress syndrome (ARDS). The geriatric population in the UAE is growing rapidly, and this group is more susceptible to respiratory diseases. According to the UAE National Bureau of Statistics, the proportion of the population aged 65 and over is expected to increase from 4.2% in 2020 to 7.3% in 2030. The respiratory monitoring device market in the UAE is also expected to benefit from the government's focus on improving healthcare infrastructure and services. The government is investing heavily in new hospitals and clinics, as well as in medical technology. This is expected to lead to an increased demand for respiratory monitoring devices.

In the United Arab Emirates, the market for respiratory equipment is meticulously segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories. Among these categories, therapeutic devices notably dominate the market with a significant market share. This can be attributed to the region's increasing prevalence of respiratory conditions, including asthma and COPD, which necessitate a wide range of therapeutic solutions. Devices such as inhalers, nebulizers, and positive airway pressure machines are essential for the management of these conditions and thus enjoy widespread adoption in the market. The consumables and accessories segment plays a pivotal role in ensuring the reliability and effectiveness of respiratory equipment. As patients and healthcare providers in the UAE seek to enhance the quality of respiratory care, the demand for high-quality consumables and accessories is increasing, thereby underscoring the importance of this category in the overall market. Monitoring and diagnostic devices, as well as diagnostic devices themselves, also hold significant market shares in the UAE. These devices are crucial for tracking the vital parameters of patients with respiratory issues and facilitating timely and accurate diagnoses, which are fundamental steps in providing appropriate treatment. Moreover, as healthcare infrastructure in the UAE continues to advance, the demand for sophisticated monitoring and diagnostic tools is on the rise, further contributing to the prominence of these categories.

The respiratory equipment market encompasses a broad spectrum of disease indications, each significantly shaping the demand for specialized respiratory devices. Chronic obstructive pulmonary disease (COPD) stands prominently within this market, representing a substantial focus due to its progressive and debilitating nature. COPD necessitates a wide array of therapeutic solutions, resulting in a significant market presence for devices such as inhalers, nebulizers, and oxygen therapy systems crucial for managing its symptoms. Additionally, sleep apnea emerges as a notable player, characterized by interrupted breathing during sleep, triggering a demand for specialized devices like continuous positive airway pressure (CPAP) machines. These devices address sleep-disordered breathing, marking a significant segment of the market. Asthma, a prevalent and chronic respiratory condition, also plays a crucial role, driving the demand for various inhalers, nebulizers, and respiratory aids. Furthermore, infectious diseases, particularly in the context of respiratory infections such as pneumonia and COVID-19, have intensified the need for diagnostic and monitoring equipment. This has amplified their market share, underlining the importance of timely detection and management of infectious respiratory ailments. Beyond these prominent indications, the category of "other disease indications" covers a spectrum of respiratory disorders, contributing collectively to the market's diversity and the need for a wide array of respiratory devices to address the evolving healthcare challenges posed by these conditions. This comprehensive market landscape emphasizes the continuous innovation and development of varied respiratory equipment to cater to the multifaceted needs of individuals facing respiratory disorders.

In the realm of end users for respiratory equipment in the United Arab Emirates (UAE), hospitals currently reign supreme, dominating the market. These healthcare institutions boast specialized facilities, a comprehensive range of respiratory devices, and a dedicated team of medical professionals, making them the primary source of care for individuals with acute and severe respiratory conditions. Hospitals play a pivotal role in delivering immediate and intensive respiratory care, positioning them as the major player in the market. However, an emerging trend suggests that in the coming years, home settings will witness a significant shift, gradually capturing a substantial market share. This transformation is driven by the evolving landscape of healthcare, marked by a growing emphasis on patient-centered care, advances in portable and user-friendly respiratory devices, and the preference for receiving medical treatment within the comfort of one's home. With the increasing prevalence of chronic respiratory conditions like COPD and sleep apnea, there's a pronounced focus on the development of home care solutions. This shift anticipates a notable market share for home settings soon, offering patients effective respiratory equipment that can be conveniently used at home, thereby enhancing patient comfort, reducing healthcare costs, and reducing the reliance on hospital-based care.

Considered in this report:
• Geography: United Arab Emirates
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United Arab Emirates Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry

ページTOPに戻る

Table of Contents